August 8, 2016
Fate Therapeutics (FATE) 5.2 M shares offering to raise $10.3 M in private placement priced at $1.96
August 4, 2016
Cesca Therapeutics (KOOL) cashes in on upside move pricing $2.5 M Registered Direct Offering
July 11, 2016
ImmunoCellular Therapeutics (NYSEMKT: IMUC) proposes $24.2 M offering
July 5, 2016
Northwest Bio (NWBO) 7.4 M share offering at $0.50
June 16, 2016
BioTime (NYSEMKT: BTX) prices 7.322 M share offering - $2.39
June 14, 2016
Spark Therapeutics (ONCE) launches offering of 3.5 M shares
June 13, 2016
Cytori (CYTX) closes unit rights offering and bags $17.1 M
June 10, 2016
BioTime’s (NYSEMKT: BYX) Cell Cure subsidiary granted $2.2 M with obligation to repay
June 7, 2016
Cytori (CYTX) extends Rights Offering subscription to Friday, 6/10, adjusting Unit pricing
June 7, 2016
StemCells (STEM) Withdraws offering
2 hours 31 min ago
RegMed Investors’ (RMi) pre-open: risk versus reward
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors